-
Understanding Fortress Biotech: http://ow.ly/l69U50yeyXy Daniel Carlson of Tailwinds Research takes a close look at what he calls a "great value opportunity," with a focus on subsidiary Avenue Therapeutics.
$FBIO$ATXI#healthcare#stocks@DanCarlson33pic.twitter.com/4uiIBX1sTN
-
-
-$0.29 EPS Expected for Avenue Therapeutics Inc
$ATXI This Quarter http://www.dailypolitical.com/?p=3374425 -
Zacks: Brokerages Anticipate Avenue Therapeutics Inc
$ATXI Will Announce Earnings of -$0.29 Per Share http://zpr.io/tKE8i -
$ATXI Major changes in stock price 3.27 % change recently https://blueequity.io/symbol/ATXI -
$ATXI considerable price movement -3.29 % change recently https://blueequity.io/symbol/ATXI -
$ATXI exactly don't sell -2.93 % change recently https://blueequity.io/symbol/ATXI -
$ATXI close. Volume too low for my liking so far. -
Avenue Therapeutics Inc
$ATXI Short Interest Down 25.8% in January http://baseballnewssource.com/?p=3910129 -
Avenue Therapeutics files U.S. application for IV tramadol; shares up 2%
$ATXI https://newsfilter.io/articles/avenue-therapeutics-files-us-application-for-iv-tramadol-shares-up-2-94d77707d411d9e702f26bebcfdfbbb7 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.